Steven C. Zimmerman spoke about his drug discovery efforts for myotonic dystrophy at the David Y. Gin Symposium.
The 2015 Larine Y. Cowan Make a Difference Award for Leadership in Diversity was given to Professor Steven Zimmerman.
- Graduate students Long Luu and Lien Nguyen, with U. of I. chemistry professor Steven Zimmerman, developed drug compounds that target three pathways associated with myotonic dystrophy type 1.
When Associate Professor of Chemical and Biomolecular Engineering Hyunjoon Kong, graduate student Cartney Smith, and colleagues set out to improve MR imaging (MRI), they turned current contrast age
A DNA-based glue has been developed by scientists at the University of Illinois, US.
There’s hope for patients with myotonic dystrophy.
Researchers at the University of Illinois have designed a small molecule that blocks an aberrant pathway associated with myotonic dystrophy type 1, the most common form of muscular dystrophy.